Mindfulness in Chronic Kidney Disease

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Chronic Kidney Diseases

In brief

This study will test whether mindfulness meditation (MM) improves sympathetic function in chronic kidney disease (CKD) and whether transcutaneous vagus nerve stimulation (tVNS) optimizes the sympatho-inhibitory effects of mindfulness meditation (MM) and restores autonomic balance in CKD patients.

Key facts

Study ID
NCT04099992
Run by
Emory University
People needed
150
Starts
2019-09-20
Expected to finish
2026-09-01
Last updated by the study team
2025-10-21

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.